Post-Authorization Safety Study to Assess the Effectiveness of the Newly Implemented Risk Minimization Measures for Topiramate: Drug Utilization Study First published 20/03/2025 Last updated 20/03/2025 EU PAS number:EUPAS1000000494 Study Planned